Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis

Background: COVID-19 patients are at high thrombotic risk. The safety and efficacy of different anticoagulation regimens in COVID-19 patients remain unclear. Methods: We searched for randomised controlled trials (RCTs) comparing intermediate- or therapeutic-dose anticoagulation to standard thrombopr...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Stefanie, Popp, Maria, Schmid, Benedikt, Stegemann, Miriam, Metzendorf, Maria-Inti, Kranke, Peter, Meybohm, Patrick, Weibel, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745419/
https://www.ncbi.nlm.nih.gov/pubmed/35011804
http://dx.doi.org/10.3390/jcm11010057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745419/
https://www.ncbi.nlm.nih.gov/pubmed/35011804
http://dx.doi.org/10.3390/jcm11010057

Ejemplares similares